Verici Dx PLC Ordinary Shares (LSE:VRCI) - Share price

Stock Report

Verici Dx PLC VRCI

Last Price

Day Change

As of 07/05/2021
11:19:20 BST | GBX
Minimum 15 Minutes Delay.

Last Close67.50p
Day Range66.00 - 68.29
Mkt Cap95.68Mil
52-Wk Range29.97 - 94.95
Yield %-

Share Price

Total Returns 07/05/2021

 Chg (%)  
More ...
Verici Dx PLC11.57 
FTSE 100 TR GBP3.91
More ...
Income Statement
Operating Profit---
Net Profit---
Reported EPS---
Balance Sheet
Current Assets--18.07
Non Current Assets--2.23
Total Assets--20.31
Current Liabilities--0.68
Total Liabilities---
Total Equity--19.62
Cash Flow
Operating Cash Flow---
Net Change in Cash---

Regulatory News

DateAuthor Headline
08/04/2021Lewis Jackson 6 Stocks for Growth and Value
Growth and value investments are often pitted against each other, but investors don't have to pick one or the other, says T. Rowe Price fund manager Scott Berg
17/12/2020Andrew Willis The 10 Biggest IPOs of 2020
These stock launches took on the pandemic, raised billions and brought some of the most exciting new opportunities
03/09/2019 Woodford Equity Income: Three Months Since Suspension
Woodford Equity Income gated three months ago today, and many of its biggest holdings have suffered share price collapses

Company Profile

Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialisation: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection ("EAR"); and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels.


Diagnostics & Research


Next Event 19/05/2021

Annual General Meeting
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
Op Mrgn0.00
EPS Grwth0.00
More ...
Record Datet.b.c.t.b.c.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.